Birmingham, United Kingdom
NCT Number: NCT01444053
Retrospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses
The purpose of this study is to examine the long term effect of ultra-violet filtering contact lenses on macular pigment density (MPOD) and accommodative function.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–43 year
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- The subject is an adapted soft contact lens wearer of at least 5 years duration of either an UV filtering contact lens or a non-UV filtering contact lens
- The subject must report wearing their contact lenses, on average, for a minimum of 5 days each week.
- The subject must have best corrected visual acuity of 6/7.5 or better in each eye.
- The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
- The subject must read and sign the statement of informed consent
- The subject must be between 18 and 43 years of age
Exclusion criteria
- On medication known to affect accommodation
- Active ocular surface pathology
- Had eye surgery
- Significant ocular tissue anomaly
- Any medical condition that may be prejudicial to the study
- Diabetes
Treatment and study plan
No Intervention
DeviceNo Intervention
Primary outcomes
-
Macular Pigment Optical Density (MPOD) after 5 years of contact lens wear
Time frame: Approximately 40 minutes
The MPOD will be assessed at a single visit will be compared between wearers of contact lenses with UV protection and those wearers of lenses without UV protection, based on their 5 year wear history.
-
Amplitude of Accommodation after 5 years of contact lens wear
Time frame: Approximately 40 minutes
Measured with autorefractor at a single visit and will be compared between wearers of contact lenses with UV protection and those wearers of lenses without UV protection, based on their 5 year wear history.
Sponsors and collaborators
Lead sponsor
Johnson & Johnson Vision Care, Inc.
Industry
Registry information
Important dates
- Study start
- 2011
- Primary completion
- 2011
- Study completion
- 2011
- First posted
- Sep 30, 2011
- Registry last updated
- Jun 20, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
VisionApp - Refraction and Presbyopia
NCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial DetailsAtropine Alone vs Atropine Plus Bifocal Spectacles for Myopia Control in Children
NCT07614113
Eye Diseases, Myopia
Faisalābad, Punjab Province, Pakistan
View Trial DetailsPerformance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS)
NCT06668246
Ametropia, Eye Diseases
Brest, France
View Trial DetailsDilated Versus Non-Dilated Wavefront Corrections for Patients With Down Syndrome
NCT05059041
Abnormalities, Multiple, Chromosome Disorders
Columbus, Ohio, United States
View Trial Details